Published in Lancet on February 21, 1976
Rapid and reliable diagnosis of Wilson disease using X-ray fluorescence. J Pathol Clin Res (2016) 0.75
Unilateral Kayser-Fleischer ring. Br J Ophthalmol (1986) 0.75
Behçet's disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) (1975) 5.68
Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma (2000) 3.65
The anti-coronary club. A dietary approach to the prevention of coronary heart disease--a seven-year report. Am J Public Health Nations Health (1966) 2.42
Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med (1998) 2.31
The association between cigarette smoking and ocular diseases. Surv Ophthalmol (1998) 2.10
Camptocormia (bent spine) in patients with Parkinson's disease--characterization and possible pathogenesis of an unusual phenomenon. Mov Disord (1999) 1.94
Cimetidine in the treatment of duodenal ulcer: a multicenter double blind study. Gastroenterology (1978) 1.93
European participation in major intensive care journals. Intensive Care Med (1995) 1.93
Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease. Exp Neurol (2012) 1.91
Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology (2004) 1.84
Laser eye injuries. Surv Ophthalmol (2000) 1.84
Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology (2001) 1.83
Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis (2004) 1.81
The Israeli Ocular Injuries Study. A nationwide collaborative study. Arch Ophthalmol (1988) 1.68
Long term effect on IOP of a stainless steel glaucoma drainage implant (Ex-PRESS) in combined surgery with phacoemulsification. Br J Ophthalmol (2005) 1.64
Retinal thickness analysis for quantitative assessment of diabetic macular edema. Arch Ophthalmol (1991) 1.62
Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis. Arch Neurol (1992) 1.61
Inflammation after axonal injury has conflicting consequences for recovery of function: rescue of spared axons is impaired but regeneration is supported. J Neuroimmunol (1994) 1.60
Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist. Neurology (1995) 1.57
Evaluating dosage compensation on the chicken Z chromosome: should effective dosage compensation eliminate sexual bias? Heredity (Edinb) (2009) 1.55
Ocular injuries in Malawi. Br J Ophthalmol (1982) 1.55
Application of rapid scanning retinal thickness analysis in retinal diseases. Ophthalmology (1997) 1.54
Brain edema after carotid surgery. Neurology (1996) 1.53
Enhanced fatigue during motor performance in patients with Parkinson's disease. Neurology (1998) 1.53
Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet (1999) 1.53
Screening for hypercoagulable states in vascular surgical practice: a preliminary study. J Vasc Surg (1990) 1.47
Travase, an effective enzyme for burn debridement. Plast Reconstr Surg (1973) 1.44
MK-801 has neuroprotective and antiproliferative effects in retinal laser injury. Invest Ophthalmol Vis Sci (1997) 1.43
Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels. Neurology (1998) 1.41
Evaluation of accommotrac biofeedback training for myopia control. Optom Vis Sci (1991) 1.41
The effect of a new rigid gas-permeable contact lens design on lactic dehydrogenase activity in rabbit tears. Isr Med Assoc J (2000) 1.41
Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease. Lancet (1999) 1.40
Precursor control of neurotransmitter synthesis. Pharmacol Rev (1980) 1.34
Reduction in regional cerebral blood flow during normal aging in man. Stroke (1980) 1.34
Tardive dyskinesia associated with metoclopramide. Br Med J (1978) 1.33
Noninvasive mapping of the normal retinal thickness at the posterior pole. Ophthalmology (1999) 1.32
Semaphorins as mediators of neuronal apoptosis. J Neurochem (1999) 1.31
Reactive hyperglycaemia in patients with acute stroke. J Neurol Sci (1976) 1.30
Isolation and characterization of a human serum cholesteryl ester transfer protein. Proc Natl Acad Sci U S A (1978) 1.30
Cerebrospinal fluid lactic acid levels in meningitis. J Pediatr (1977) 1.28
Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res (1980) 1.27
Individual variability in the diurnal intraocular pressure curve. Ophthalmology (1993) 1.27
Increased plasma endothelin-1 in acute ischemic stroke. Stroke (1992) 1.26
Concurrent and subsequent serum cholesterol of breast- and formula-fed infants. Am J Clin Nutr (1975) 1.25
Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease. Clin Neuropharmacol (1998) 1.20
Acute "upside down" reversal of vision in transient vertebrobasilar ischemia. Neurology (1987) 1.20
Lipoprotein lipase of cultured mesenchymal rat heart cells. I. Synthesis, secretion and releasability by heparin. Biochim Biophys Acta (1978) 1.20
Embolism from vertebral artery origin occlusive disease. Neurology (1992) 1.16
Effect of chronic atrial fibrillation on regional cerebral blood flow. Stroke (1980) 1.16
Yellow nail syndrome. Postgrad Med J (1997) 1.16
Self-assembled magnetic surface swimmers. Phys Rev Lett (2009) 1.16
Very low density lipoprotein. Metabolism of phospholipids, cholesterol, and apolipoprotein C in the isolated perfused rat heart. J Clin Invest (1978) 1.15
Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine? Lancet (1979) 1.14
Retinal thickness change after focal laser treatment of diabetic macular oedema. Br J Ophthalmol (1994) 1.14
Risk factors for coronary artery disease in patients with acute myocardial infarction. Effects of age, sex and ethnicity. Isr J Med Sci (1981) 1.13
Extrahepatic portal vein aneurysm: a case report and review of the literature. Cardiovasc Surg (2002) 1.13
Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol (2000) 1.13
Intelligence, education, and myopia in males. Arch Ophthalmol (1987) 1.12
Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism. Neurology (1981) 1.11
Eye injuries in children in Israel. A nationwide collaborative study. Arch Ophthalmol (1990) 1.11
Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. Proc Natl Acad Sci U S A (1998) 1.11
Isolation and characterization of the apolipoprotein E receptor from canine and human liver. J Biol Chem (1986) 1.10
Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson's disease. Neurosci Lett (2001) 1.10
Ocular injury by mustard gas. Surv Ophthalmol (1997) 1.09
The prognostic value of the CT scan in conservatively treated patients with intracerebral hematoma. Stroke (1984) 1.09
Skin biopsy for assessment of autonomic denervation in Parkinson's disease. J Neural Transm (Vienna) (2006) 1.09
Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med (1999) 1.08
Paroxysmal dystonia as the initial manifestation of multiple sclerosis. Arch Neurol (1984) 1.08
Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci Lett (2005) 1.06
Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease. Mov Disord (2001) 1.05
Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism. Ann Neurol (1980) 1.05
Integral therapeutic potential of bone marrow mesenchymal stem cells. Curr Drug Targets (2005) 1.05
Enhanced oxidative stress and altered antioxidants in brains of Bcl-2-deficient mice. J Neurochem (1998) 1.05
Enhanced metabolism of normolipidemic human plasma very low density lipoprotein in cultured cells by exogenous apolipoprotein E-3. Arteriosclerosis (1988) 1.04
Direct localisation of beta-adrenoceptor sites in rat cerebellum by a new fluorescent analogue of propranolol. Nature (1976) 1.04
Temporal arteritis in Israel. A review of 47 patients. J Rheumatol (1979) 1.04
Recovery of visual response of injured adult rat optic nerves treated with transglutaminase. Science (1994) 1.04
Induction of neuronal apoptosis by Semaphorin3A-derived peptide. Brain Res Mol Brain Res (2000) 1.03
Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology (1996) 1.02
Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol (1995) 1.02
Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson's disease. Arch Neurol (1979) 1.02
Hemiballismus: detection of focal hemorrhage in subthalamic nucleus by CT scan. Ann Neurol (1978) 1.02
Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. Cytotherapy (2008) 1.01
Quinidine hypersensitivity and liver involvement. A survey of 32 patients. Gastroenterology (1976) 1.00
Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion. J Clin Invest (1994) 1.00
Excellent outcome of renal transplantation in patients with Fabry's disease. Transplantation (2000) 1.00
Decreased fibrinolysis in Behçet's disease. Thromb Diath Haemorrh (1973) 0.99
Tumor necrosis factor facilitates regeneration of injured central nervous system axons. Brain Res (1991) 0.99
The role of excitotoxicity in organophosphorous nerve agents central poisoning. Trends Pharmacol Sci (1997) 0.99
Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease. Exp Neurol (1996) 0.99
Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome. Transplant Proc (1988) 0.99
The site of dopamine formation in rat striatum after L-dopa administration. J Pharmacol Exp Ther (1981) 0.99
Epidemiology of temporal arteritis in Israel. Isr J Med Sci (1982) 0.99
Diagnosis of "non-organic" limb paresis by a novel objective motor assessment: the quantitative Hoover's test. J Neurol (1998) 0.98
Redefining papillorenal syndrome: an underdiagnosed cause of ocular and renal morbidity. Ophthalmology (2001) 0.98
Mechanism of the hypertriglyceridemia induced by tumor necrosis factor administration to rats. Biochim Biophys Acta (1989) 0.98
Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Brain Res (2000) 0.98
Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Pharmacol Biochem Behav (1980) 0.97